- MCTC Holdings Inc. is a company dedicated to research and development of innovative infusion technologies in the fast-growing area of cannabinoids sciences
- The company recently announced that it is expanding on development infusion technologies to include lesser known cannabinoids such as cannabinol (CBN) and THC-V, which have possible applications in product that promote sleep and control appetite
- MCTC has thus far filed five patents and expects to file at least several additional over the coming months
- The company’s aim is to make the current generation of hemp extract and cannabinoid technologies obsolete
Cannabis infusion technology developer MCTC Holdings Inc. (OTC: MCTC), a Delaware-registered, fully reporting company, is expanding its research beyond the four patents the company has developed with the aim of establishing novel applications of polymeric nanoparticles of cannabinol (CBN) and cannabinoid glycosides.
Since MCTC Holdings reorganized itself in June, the company has focused its corporate efforts on the fast-growing cannabis industry, specifically the development of products that build on proprietary research into exotic cannabinoid isolation, bioenhancement of cannabinoids and…
NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.